406 Bio and Pharmaceutical Process Design

Wednesday, November 6, 2013: 8:30 AM
Plaza B (Hilton)
Description:
This sessions covers pharmaceutical process design for both biologics and small molecules.

Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum
Co-Sponsor(s):
Systems and Process Design (10A)

Chair:
Jennifer Kuehne-Willmore
Email: kuehnewillmoreje@lilly.com

Co-Chair:
Jose Cardoso Menezes
Email: cardoso.menezes@ist.utl.pt


8:30 AM
(406a) Rapid Process Development of a Pharmaceutical Intermediate for a Late-Stage Compound
Aaron M. Chockla, Tamas Benkovics, Brenda Remy and Chris Sfouggatakis

8:55 AM
(406b) Development of a pH Driven, Reactive Crystallization of a Pharmaceutical Compound
Andrew S. Cosbie, Seth Huggins, Tedrow Jason and Henry Morrison

9:20 AM
(406c) Development of Controlled Agglomeration During Vacuum Agitated Filter Drying for An Active Pharmaceutical Ingredient
Michelle Staben Wobker, Dennis Ward, Peter R. Hamilton and R. Rahn McKeown

9:45 AM
Break

10:10 AM
(406e) Optimal Design of Antibody Downstream Process of Biopharmaceutical Manufacturing
Songsong Liu, Ana S. Simaria, Suzanne S. Farid and Lazaros G. Papageorgiou

10:35 AM
(406f) An Integrated PAT Approach for a Lab Scale Bioreactor IgG3 Cell Culture Process Real Time Monitoring: A Feasibility Study
Huiquan Wu
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum
<< Previous Session | Next Session >>